8.745

0.34% 0.025

Enfusion Inc (ENFN)

Overview News Price History Option Chain Discussions Forecast

Enfusion Inc stock is traded at $8.745, with a volume of 330.16K. It is up +0.34% in the last 24 hours and down -2.78% over the past month. Enfusion Inc is a software-as-a-service (SaaS) provider focused on transforming the investment management industry. Its solutions are designed to eliminate technology and information barriers, empowering investment managers to make and execute an informed investment decisions in real-time. It simplifies investment and operational workflows by unifying mission-critical systems and coalescing data into a single dataset resulting in a single source of truth. It generates maximum revenue from Americas, followed by Asia Pacific and Europe, Middle East, and Africa.

Previous Close:

$8.72

Open:

$8.87

24h Volume:

330.16K

Relative Volume:

0.91

Market Cap:

$824.91M

Revenue:

$174.54M

Net Income/Loss:

$6.03M

P/E Ratio:

109.31

EPS:

0.08

Net Cash Flow:

$15.96M

1W Performance:

-5.41%

1M Performance:

-2.78%

6M Performance:

-8.57%

1Y Performance:

+1.74%

1-Day Range:

$8.74

$8.91

1-Week Range:

$8.66

$9.375

52-Week Range:

$7.52

$10.45

Enfusion Inc Stock (ENFN) Company Profile

Name

Enfusion Inc

Sector

Technology (778)

Industry

Software - Application (242)

Phone

(312) 253-9800

Address

125 SOUTH CLARK STREET, SUITE 750, CHICAGO

Employee

1,102

Twitter

Next Earnings Date

2024-08-06

Latest SEC Filings

ENFN's Discussions on Twitter

Enfusion Inc Stock (ENFN) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Apr-03-23	Initiated	Piper Sandler	Neutral
Mar-15-23	Initiated	JP Morgan	Neutral
Jan-04-23	Downgrade	BofA Securities	Neutral → Underperform
Jan-03-23	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Oct-03-22	Downgrade	BofA Securities	Buy → Neutral
Nov-15-21	Initiated	BofA Securities	Buy
Nov-15-21	Initiated	Credit Suisse	Neutral
Nov-15-21	Initiated	Goldman	Neutral
Nov-15-21	Initiated	Morgan Stanley	Equal-Weight
Nov-15-21	Initiated	Piper Sandler	Overweight
Nov-15-21	Initiated	Stifel	Buy
Nov-15-21	Initiated	William Blair	Outperform

View All

Enfusion Inc Stock (ENFN) Latest News

08:16 AM

Enfusion, Inc. (NYSE:ENFN) Q3 2024 Earnings Call Transcript - Insider Monkey

08:16 AM

Nov 04, 2024

Enfusion, Inc. Reports Strong Q3 2024 Results - TipRanks

Nov 04, 2024

Earnings call: Enfusion reports robust Q3 growth with strong client gains - Investing.com Canada

Nov 04, 2024

Discover 3 US Growth Companies With High Insider Ownership - Simply Wall St

Nov 04, 2024

Here's What Key Metrics Tell Us About Enfusion (ENFN) Q3 Earnings - Yahoo Finance

Nov 04, 2024

Enfusion Q3 Revenue Rises; Revises Outlook - Nasdaq

Nov 04, 2024

Enfusion earnings missed, revenue fell short of estimates By Investing.com - Investing.com UK

Nov 04, 2024

Enfusion Announces Third Quarter 2024 Results - StockTitan

Nov 04, 2024

Nov 01, 2024

When the Price of (ENFN) Talks, People Listen - Stock Traders Daily

Nov 01, 2024

Oct 30, 2024

Enfusion: 3 Strength, 3 Caveats, 3 Ways For Extra Income And Margin Of Safety (ENFN) - Seeking Alpha

Oct 30, 2024

Oct 29, 2024

Why Private Equity Will Buyout Enfusion (NYSE:ENFN) - Seeking Alpha

Oct 29, 2024

Enfusion, Inc. (NYSE:ENFN) Short Interest Update - MarketBeat

Oct 29, 2024

FTV Capital Named to Inc.’s Founder-Friendly Investors List for Fourth Consecutive Year - StockTitan

Oct 29, 2024

Oct 28, 2024

Enfusion (ENFN) to Release Quarterly Earnings on Monday - MarketBeat

Oct 28, 2024

Oct 24, 2024

Enfusion's general counsel Matthew Campobasso sells $6,032 in stock - Investing.com

Oct 24, 2024

Enfusion's general counsel Matthew Campobasso sells $6,032 in stock By Investing.com - Investing.com Canada

Oct 24, 2024

Oct 21, 2024

Enfusion, Inc.'s (NYSE:ENFN) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong? - Yahoo Finance

Oct 21, 2024

(ENFN) On The My Stocks Page - Stock Traders Daily

Oct 21, 2024

Oct 18, 2024